Related Experiment Video
Updated: Jul 19, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
The impact of Verapamil for radial access in diagnostic cerebrovascular angiograms: A retrospective case-control
Dominic Romeo1, Mohamed M Salem1, Georgios S Sioutas1
1Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.
Insights
Verapamil in neuroendovascular procedures did not significantly reduce vasospasm and was linked to hives. Prophylactic Verapamil may not be necessary for radial or ulnar artery catheterization.
Area of Science:
- Neuroendovascular procedures
- Vascular access
- Pharmacology
Background:
- Medication cocktails are used during radial artery (RA) or ulnar artery (UA) catheterization for neuroendovascular procedures to prevent vasospasm.
- These cocktails often include Verapamil, a calcium channel blocker, despite a lack of established benefit.
Purpose of the Study:
- To analyze the outcomes of patients who received Verapamil versus those who did not during wrist access for neuroendovascular procedures.
- To determine if Verapamil reduces vasospasm or increases the incidence of side effects like skin rashes.
Main Methods:
- A retrospective review of a prospective log of patients undergoing diagnostic cerebral angiograms via RA/UA access.
- Patients were divided into Verapamil and non-Verapamil cohorts.
- Primary outcomes assessed were forearm skin rashes (hives) and RA/UA spasms.
Main Results:
- 221 patients underwent 241 procedures; 149 received Verapamil and 92 did not.
- 2.7% of patients in the Verapamil group developed hives, compared to 0% in the non-Verapamil group.
- One patient (1.1%) in the non-Verapamil group experienced vasospasm, while no vasospasm was reported in the Verapamil group.
Conclusions:
- Verapamil administration during wrist access for diagnostic cerebral angiograms was associated with periprocedural hives.
- Verapamil was not associated with a significant reduction in vasospasm compared to the non-Verapamil group.
- Prophylactic Verapamil may not be necessary for these neuroendovascular procedures.
Abstract:
IntroductionDifferent combinations of medications are utilized during wrist access for radial artery (RA) or ulnar artery (UA) catheterization in neuroendovascular procedures to preclude vasospasm. These "cocktails" commonly include the calcium channel blocker Verapamil, without established benefit. We analyze outcomes in patients with and without Verapamil in their "cocktail" by using a case-control cohort of our single-center experience.MethodsA prospective log of consecutive patients who underwent diagnostic cerebral angiograms using RA/UA access was retrospectively reviewed, and patients were grouped into Verapamil and non-Verapamil cohorts. The primary outcomes assessed were the presence of forearm skin rashes (hives) and RA/UA spasms. Our initial management included Verapamil (5 mg) in the cocktail, but Verapamil was removed after we noticed the development of hives in multiple patients immediately following its injection.ResultsA total of 221 patients underwent 241 RA/UA diagnostic cerebral angiograms and were included in our analysis. One hundred and forty-nine patients (61.8%) underwent catheterization with Verapamil and 92 (38.2%) were catheterized without it. Four of the 149 patients in the Verapamil group (2.7%) developed hives during the procedure and were treated with Benadryl (25 mg). Of the 92 patients who did not receive Verapamil, there were zero (0%) cases of hives and one (1.1%) case of vasospasm.ConclusionVerapamil in the "cocktail" for wrist access diagnostic cerebral angiograms was associated with periprocedural hives, but not associated with a significant reduction in spasm compared to the non-Verapamil group. Our findings suggest that the administration of prophylactic Verapamil for these procedures may not be necessary.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Cardiac Catheterization IV: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview

